Genomics and Proteomics are complementary technologies of biological research

Research and Markets have announced the addition of the 'Revolutionise Drug Discovery through Genomics and Proteomics Study report to their offering.

(PRWEB) February 8, 2004 --Genomics and Proteomics are complementary technologies of biological research. The potential of these technologies for biomedical revolution will be realized by integrating them into the drug discovery process at every stage from hypothesis generation to clinical evaluation.

This report explores the role of Genomics and Proteomics in the drug discovery market. It also provides an outlook for this market.

For a complete index of this report click on http://www.researchandmarkets.com/reports/16637

About Research and Markets Ltd.
Research and Markets Ltd. are Europe's largest resource for market research. R&M distribute thousands of major research publications from the world's leading publishers, consultants and market analysts. R&M provide you with the latest forecasts on international and regional markets, key industries, the top companies, new products and the latest market trends.

For additional information on ResearchandMarkets.com, their range of reports or their value-added services, visit their web site at http://www.researchandmarkets.com or mailto:press@researchandmarkets.com